Skip to content

Clinical Trial on the Effectiveness and Safety of Jiuwei Zhuhuang Powder in Treating Pediatric Pneumonia

Clinical Trial on the Effectiveness and Safety of Jiuwei Zhuhuang Powder in Treating Pediatric Pneumonia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046451
Enrollment
Unknown
Registered
2021-05-15
Start date
2018-01-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Pneumonia

Interventions

Experimental group:Jiuwei Zhuhuang Powder combined with Amoxicillin Sodium and Sulbactam Sodium
Control group :Amoxicillin sodium and sulbactam sodium alone

Sponsors

Tibet Autonomous Region Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of Western medicine in children with pneumonia and the diagnostic criteria of Chinese medicine in pneumonia and cough; 2.Aged 1 to 14 years; 3.Course of disease <= 48 hours; and not receiving relevant drug treatment; 4.Those who have signed the informed consent form by the legal guardian.

Exclusion criteria

Exclusion criteria: 1.Severe pneumonia; 2.Patients with moderate to severe malnutrition; 3.Liver function ALT, AST, TBil >1.5 ULN, and blood creatinine > ULN; 4.Patients with severe primary diseases of the heart, brain, liver, kidney and hematopoietic system, patients with malignant tumors; 5.People with severe complications such as convulsions; 6.People with allergies or allergies to the components of Jiuwei Zhuhuang San, those who are allergic to penicillin or other ß-lactam antibiotics, and those who are allergic to sulbactam; 7.Patients who have participated in other clinical trials in the past 4 weeks or are participating in clinical trials of other drugs; 8.Doctors think it is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Cough symptom score;

Secondary

MeasureTime frame
temperature;Symptoms and signs score;

Countries

China

Contacts

Public ContactDa zhen

Tibet Cheezheng Tibetan Medicine Co.,Ltd

djzm@qzh.cn+86 18108916752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026